In contrast, IL-10 levels were significantly reduced in pEEVGmCSF-b7.1-treated mice (both in the spleen and tumour) when compared with the pGT141GmCSF-b7.1-treated group (P<0.05) and all other groups analysed. The gene discussed is IL10; the disease is neoplasm.